Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?

Eur J Heart Fail. 2018 Apr;20(4):627-629. doi: 10.1002/ejhf.1047. Epub 2017 Oct 30.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiotonic Agents / therapeutic use*
  • Cyclic AMP / metabolism*
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Heart Failure* / drug therapy
  • Heart Failure* / pathology
  • Heart Failure* / physiopathology
  • Humans
  • Myocardial Contraction / drug effects*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology

Substances

  • Cardiotonic Agents
  • Glucagon-Like Peptide 1
  • Cyclic AMP